Bud Light Still Suffering Fallout From 2023 LGBT-Endorsement

LGBT,

The Wall Street Journal reports that Bud Light is still suffering fallout more than a year after its pro-LGBT marketing disaster, writing, “The former favorite has tumbled to the No. 3 spot behind Modelo Especial and Michelob Ultra, recent sales data show.”

Bud Light has long been the bestselling beer in America. But in April of 2023 Bud Light managed to singlehandedly overthrow itself after Anheuser-Busch sent transgender social media influencer Dylan Mulvaney a novelty can of Bud Light with Mulvaney’s picture on it. Mulvaney posted a video of himself dressed like Audrey Hepburn showcasing the Bud Light can –which led to backlash and boycotts from Bud Light drinkers nationwide. The company’s subsequent backpedaling simply managed to offend customers and LGBT activists alike.

The latest report from the Wall Street Journal notes that as sales have dropped, Anheuser-Busch has lost between 5% and 7.5% of shelf space among alcohol retailers this year.

To be clear, none of this is intended to endorse alcohol, but it underscores how Anheuser-Busch has suffered long-term damage to one of its most iconic brands because some of its core customers—Bud Light drinkers—don’t support corporate, pro-LGBT pandering.

Some have speculated that this type of backlash is what prompted companies like Target to quietly reduce their Pride-themed merchandise this year.

It’s troubling to see multimillion dollar corporations use their wealth and influence to promote radical LGBT ideologies — but it’s encouraging to see consumers vote with their feet by choosing not to support this agenda.

As some of have said, it proves that the “silent majority” is real when it comes to the transgender issue.

All of that ought to show how out-of-step these corporations are with everyday Americans.

Articles appearing on this website are written with the aid of Family Council’s researchers and writers.

READ MORE

Scottish Government Advised to Protect Kids from Puberty Blockers

LGBT, ,

Recently the BBC reported the Scottish government “has been advised to formally pause puberty blockers until further research has been carried out.” This comes as countries in Europe continue to take steps to protect children from puberty blockers and other sex-change procedures.

In 2022 the U.K.’s National Health Services closed its Tavistock gender clinic that gave puberty blockers and cross-sex hormones to children for many years.

A government investigation revealed healthcare professionals at the Tavistock clinic pressured families into subjecting their children to puberty blockers and cross-sex hormones despite an obvious lack of scientific evidence and inadequate mental health screenings for children with gender dysphoria.

Earlier this year, the NHS officially banned healthcare professionals from prescribing puberty blockers to children.

In 2021, a major hospital in Sweden announced that it would no longer give puberty blockers and cross-sex hormones to kids, and last year the U.S. Food and Drug Administration added a warning label to puberty blockers in America after biological girls developed swelling in the brain.

In 2021, lawmakers in Arkansas also overwhelmingly passed the Save Adolescents From Experimentation (SAFE) Act.

The SAFE Act is a good law that prevents doctors in Arkansas from performing sex-change surgeries on children or giving them puberty blockers and cross-sex hormones.

Over the past three years, reports from Europe and elsewhere have shown time and again that Arkansas was right to pass the SAFE Act.

Unfortunately, the SAFE Act has been tied up in court since 2021. However, we believe our courts ultimately will recognize that the SAFE Act is a good law and uphold it as constitutional.

Articles appearing on this website are written with the aid of Family Council’s researchers and writers.

READ MORE